Subthalamic Nucleus Stimulation

(STN)

New Horizons in the Treatment of Parkinson's Disease

An exciting recent development in the neurosurgical treatment of advanced Parkinson's Disease is Subthalamic Nucleus (STN) deep brain Stimulation (DBS). This procedure is performed at New York University School of Medicine under the direction of P. J. Kelly M.D. (Professor and Chairman Department of Neurosurgery) and A. Beric M.D. (Director of Clinical Neurophysiology and Movement Disorder Section - Department of Neurology) under an investigational protocol pending FDA approval. South Shore Neurologic Associaties Movement Disorder Section has been working closely with Dr Kelly and Dr Beric to identify those people on Long Island, New York with Parkinson's Disease whose quality of life, despite aggressive medical management, has been unacceptable and that might benefit from this novel approach to treatment.

What is Subthalamic Nucleus Stimulation?

 

Who is a candidate for STN Stimulation?

 

Can you describe the STN surgical procedure?

 

What are the risks of the STN procedure?

 

 Frequently asked questions about STN

 

 What are the results of the STN procedure?

 

 

For More Information, please contact directly:

Mark Gudesblatt, M.D.
South Shore Neurologic Associates
280 Main Street, Bay Shore, New York, 11706
631-666-3939
Fax: 631-665-6844
 
Anne O'Sullivan, Administrator
NYU Center for the Study & Treatment of Movement Disorders
530 First Avenue, New York, New York, 10016
212-263-1483
Fax: 212-263-8031